Breast Cancer and a Separate Intrahepatic Cholangiocarcinoma in a 35-Year-Old Woman
This breast cancer diagnosis at a glance
- Subtype
- Invasive Ductal Carcinoma
- Biomarkers
- ER-positive, PR-positive, HER2/CerbB-2 positive
- Sex
- Female
- Treatment
- surgery and endocrine therapy
- Outcome
- Care Ongoing
Treatment course, step by step
- Underwent left breast surgery followed by radical mastectomy with sentinel lymph node biopsy.
- Received postoperative goserelin plus letrozole as endocrine maintenance.
What happened, in summary
A 35-year-old woman presented with a left breast mass in September 2021. Initial breast surgery showed invasive ductal carcinoma with estrogen- and progesterone-receptor positivity and CerbB-2 positivity. She later underwent a left radical mastectomy with sentinel lymph node biopsy. Only a small amount of residual lobular carcinoma in situ was found in the breast specimen, and the sentinel lymph node was negative. She received goserelin plus letrozole as postoperative endocrine maintenance.
At the same time, imaging showed multiple masses in the right side of the liver and enlarged abdominal lymph nodes. These findings were initially suspected to represent metastatic breast cancer. A liver operation in December 2021 changed the picture: pathology showed a separate primary intrahepatic cholangiocarcinoma rather than breast-cancer spread.
The liver cancer later recurred and required its own treatment, including capecitabine, immunotherapy, and liver-artery embolization. The liver cancer later recurred and required additional treatment. Her breast-cancer care continued with surgery and endocrine maintenance, without confirmed distant breast-cancer spread.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- ER Positive Breast Cancer 242 stories
- Endocrine Therapy for Breast Cancer 36 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer